Astellas Pharma Inc.
Clinical trials sponsored by Astellas Pharma Inc., explained in plain language.
Astellas Pharma Inc.
4503
TOKYO
Global pharmaceutical company developing medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New eye injection aims to slow vision loss from Age-Related macular degeneration Results expected Jun 2027 (estimated)